Heres the update I received via email: NanoLogi
Post# of 9122
NanoLogix Update
N-Assay press release and event recap for Central Association of Ostetricians & Gynecologists
The NanoLogix N-Assay rapid bacteria diagnostic was unveiled at the CAOG Annual meeting held in Las Vegas, Nevada, 27-29 October 2016. Jonathan Faro, MD, PhD presented the technology to the attendants at poster sessions held on the 27th and 28th and was awarded the Judges' Choice Award for Best Gynecology Presentation. The award was both a Certificate and financial. Dr. Faro stated "We are very excited to have seen how well our data was received at the CAOG Meeting. There were many excellent presentations and I was able to meet many leaders in their fields."
A senior CAOG member stated "This is great technology, truly a disruptive tech, we need it for rapid detection and determination of antibiotic resistance, it's essential."
For reference:
According to Clayton M. Christensen, a Harvard Business School professor, a disruptive technology is a new emerging technology that unexpectedly displaces an established one. ... The Innovator's Dilemma by Clayton M. Christensen.
Follow this link to the Press Release and Presentation PDF:
http://www.marketwired.com/press-release/nano...171323.htm
NanoLogix CEO Bret Barnhizer and shareholders from Hawaii and Texas also attended.